Cargando…

Cryptococcosis complicating diabetes mellitus: a scoping review

BACKGROUND: A better understanding of the epidemiology of cryptococcal infection in HIV-negative individuals is an international research interest. Immune dysfunction in diabetes mellitus (DM) significantly increases the risk of acquiring and reactivation of infection due to Cryptococcus neoformans....

Descripción completa

Detalles Bibliográficos
Autores principales: Nsenga, Lauryn, Kajjimu, Jonathan, Olum, Ronald, Ninsiima, Sandra, Kyazze, Andrew Peter, Ssekamatte, Phillip, Kibirige, Davis, Baluku, Joseph Baruch, Andia-Biraro, Irene, Bongomin, Felix
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111545/
https://www.ncbi.nlm.nih.gov/pubmed/33996076
http://dx.doi.org/10.1177/20499361211014769
_version_ 1783690523866824704
author Nsenga, Lauryn
Kajjimu, Jonathan
Olum, Ronald
Ninsiima, Sandra
Kyazze, Andrew Peter
Ssekamatte, Phillip
Kibirige, Davis
Baluku, Joseph Baruch
Andia-Biraro, Irene
Bongomin, Felix
author_facet Nsenga, Lauryn
Kajjimu, Jonathan
Olum, Ronald
Ninsiima, Sandra
Kyazze, Andrew Peter
Ssekamatte, Phillip
Kibirige, Davis
Baluku, Joseph Baruch
Andia-Biraro, Irene
Bongomin, Felix
author_sort Nsenga, Lauryn
collection PubMed
description BACKGROUND: A better understanding of the epidemiology of cryptococcal infection in HIV-negative individuals is an international research interest. Immune dysfunction in diabetes mellitus (DM) significantly increases the risk of acquiring and reactivation of infection due to Cryptococcus neoformans. Risk factors and outcomes of cryptococcosis in DM are not well documented. OBJECTIVE: The objective of this study was to determine the clinical characteristics and outcomes of cryptococcal infections in persons living with DM. METHODS: MEDLINE (via PubMed), EMBASE, and the Cochrane Library databases were searched in November 2020. The searches covered the period between 1980 and 2020.We included studies that reported confirmed cryptococcosis in patients with DM. Reference lists of included articles were also searched, and additional studies were included if appropriate. No language restriction was applied. Single case reports, case series and original articles were included whereas review articles were excluded. RESULTS: A total of 28 studies (24 single case reports, 4 retrospectives) were included involving 47 unique patients from Asia (17 cases), North America (six cases), South America (three cases) and Africa (two cases). Men constituted 75% (n = 18) of the cases. Median age was 60.5 (range: 27–79) years. The majority of the patients had cryptococcal meningitis (68.1%, n = 32) followed by disseminated cryptococcosis (6.4%, n = 7), and others (isolated cutaneous disease one, peritonitis one, pleural one, thyroid one, adrenal one). Diagnosis was achieved through either culture and microscopy (38/47), cryptococcal antigen tests (9/47) or histopathology (9/47) singly or in a combination. All-cause mortality was 38.3% (n = 18). Among those with meningitis mortality was 36.2%. CONCLUSION: A wide spectrum of cryptococcal infections with varying severity occurs in DM. Mortality remains unacceptably high. There is a need for more studies to characterize better cryptococcal disease in DM.
format Online
Article
Text
id pubmed-8111545
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-81115452021-05-14 Cryptococcosis complicating diabetes mellitus: a scoping review Nsenga, Lauryn Kajjimu, Jonathan Olum, Ronald Ninsiima, Sandra Kyazze, Andrew Peter Ssekamatte, Phillip Kibirige, Davis Baluku, Joseph Baruch Andia-Biraro, Irene Bongomin, Felix Ther Adv Infect Dis Review BACKGROUND: A better understanding of the epidemiology of cryptococcal infection in HIV-negative individuals is an international research interest. Immune dysfunction in diabetes mellitus (DM) significantly increases the risk of acquiring and reactivation of infection due to Cryptococcus neoformans. Risk factors and outcomes of cryptococcosis in DM are not well documented. OBJECTIVE: The objective of this study was to determine the clinical characteristics and outcomes of cryptococcal infections in persons living with DM. METHODS: MEDLINE (via PubMed), EMBASE, and the Cochrane Library databases were searched in November 2020. The searches covered the period between 1980 and 2020.We included studies that reported confirmed cryptococcosis in patients with DM. Reference lists of included articles were also searched, and additional studies were included if appropriate. No language restriction was applied. Single case reports, case series and original articles were included whereas review articles were excluded. RESULTS: A total of 28 studies (24 single case reports, 4 retrospectives) were included involving 47 unique patients from Asia (17 cases), North America (six cases), South America (three cases) and Africa (two cases). Men constituted 75% (n = 18) of the cases. Median age was 60.5 (range: 27–79) years. The majority of the patients had cryptococcal meningitis (68.1%, n = 32) followed by disseminated cryptococcosis (6.4%, n = 7), and others (isolated cutaneous disease one, peritonitis one, pleural one, thyroid one, adrenal one). Diagnosis was achieved through either culture and microscopy (38/47), cryptococcal antigen tests (9/47) or histopathology (9/47) singly or in a combination. All-cause mortality was 38.3% (n = 18). Among those with meningitis mortality was 36.2%. CONCLUSION: A wide spectrum of cryptococcal infections with varying severity occurs in DM. Mortality remains unacceptably high. There is a need for more studies to characterize better cryptococcal disease in DM. SAGE Publications 2021-05-05 /pmc/articles/PMC8111545/ /pubmed/33996076 http://dx.doi.org/10.1177/20499361211014769 Text en © The Author(s), 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Review
Nsenga, Lauryn
Kajjimu, Jonathan
Olum, Ronald
Ninsiima, Sandra
Kyazze, Andrew Peter
Ssekamatte, Phillip
Kibirige, Davis
Baluku, Joseph Baruch
Andia-Biraro, Irene
Bongomin, Felix
Cryptococcosis complicating diabetes mellitus: a scoping review
title Cryptococcosis complicating diabetes mellitus: a scoping review
title_full Cryptococcosis complicating diabetes mellitus: a scoping review
title_fullStr Cryptococcosis complicating diabetes mellitus: a scoping review
title_full_unstemmed Cryptococcosis complicating diabetes mellitus: a scoping review
title_short Cryptococcosis complicating diabetes mellitus: a scoping review
title_sort cryptococcosis complicating diabetes mellitus: a scoping review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111545/
https://www.ncbi.nlm.nih.gov/pubmed/33996076
http://dx.doi.org/10.1177/20499361211014769
work_keys_str_mv AT nsengalauryn cryptococcosiscomplicatingdiabetesmellitusascopingreview
AT kajjimujonathan cryptococcosiscomplicatingdiabetesmellitusascopingreview
AT olumronald cryptococcosiscomplicatingdiabetesmellitusascopingreview
AT ninsiimasandra cryptococcosiscomplicatingdiabetesmellitusascopingreview
AT kyazzeandrewpeter cryptococcosiscomplicatingdiabetesmellitusascopingreview
AT ssekamattephillip cryptococcosiscomplicatingdiabetesmellitusascopingreview
AT kibirigedavis cryptococcosiscomplicatingdiabetesmellitusascopingreview
AT balukujosephbaruch cryptococcosiscomplicatingdiabetesmellitusascopingreview
AT andiabiraroirene cryptococcosiscomplicatingdiabetesmellitusascopingreview
AT bongominfelix cryptococcosiscomplicatingdiabetesmellitusascopingreview